Ocean Biomedical, Inc. is a US-based pharmaceutical company focused on bridging the gap between basic research and clinical development to provide new medicines to patients in need. With an ESG risk rating score of 39.8, the company is considered high risk in terms of environment, sustainability, and governance. Join Ocean Biomedical in their mission to innovate and improve healthcare solutions.